Phase
Condition
Gastrointestinal Diseases And Disorders
Lactose Intolerance
Hyponatremia
Treatment
Placebo
De Simone formulation probiotic
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Prior diagnosis of bile acid malabsorption documented in the medical history basedon
either serum C4 >52.5ng/mL, or
fecal 48h total BA excretion >2337 μmol/48h, or
primary BA >5% 48h stool collection or >10% in single stool sample.
7-day stool dairy with an average stool consistency based on the Bristol Stool FormScale, BSFS, with a grade greater than 5. Note: If Inclusion criteria 3 is not met,participants may choose to have their blood drawn clinically to further determineeligibility.
For women of childbearing potential
A negative urine pregnancy test prior to dispensing the study product
Agreement to comply with approved methods of contraception during the wholestudy: unless they meet the criteria of post-menopausal, i.e. 12 months ofspontaneous amenorrhea, women of child-bearing potential, defined as all womenphysiologically capable of becoming pregnant, including women whose career,lifestyle, or sexual orientation precludes intercourse with a male partner,should use one or more of the following acceptable methods of contraceptionthat should be maintained throughout the study:
Surgical sterilization
Hormonal contraception (implantable, patch, oral, intra-muscular)
Intra-uterine device
Double barrier method (diaphragm plus condom)
At the discretion of the investigator, total abstinence is acceptable incases where age, career, lifestyle, or sexual orientation of the patientensures compliance
Exclusion
Exclusion criteria:
Use of oral antibiotics and probiotics within the last 4 weeks.
Pregnancy or lactation.
Concomitant use of bile acid sequestrants, must stop 10 days before starting 7-daystool dairy and for the duration of the study.
History of ileal resection.
Diabetes mellitus (type 1)
BMI ≥ 40 kg/m^2
Diagnosis of gastrointestinal diseases that are associated with inflammation such asinflammatory bowel diseases and celiac diseases or gastrointestinal infection in theprior 4 weeks
Any condition or personal circumstance that, in the opinion of the investigator,renders the subject unlikely or unable to comply with the full study protocol orcould interfere with the study assessments
Study Design
Study Description
Connect with a study center
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.